Nephros Inc. Reports Significant Turnaround with $558K Net Income and $0.05 EPS, Rebounding from Previous Losses

Reuters

05-23

Nephros Inc. Reports Significant Turnaround with $558K Net Income and $0.05 EPS, Rebounding from Previous Losses

Nephros Inc. has released its financial results for the first quarter of 2025, showing a net income of $558,000, a significant improvement compared to the net loss of $169,000 reported in the same quarter of the previous year. The company's earnings per share $(EPS)$, both basic and diluted, stood at $0.05, compared to a loss of $0.02 per share in the first quarter of 2024. The company's EBITDA for the quarter was $585,000, marking a substantial turnaround from the negative EBITDA of $159,000 in the previous year's first quarter. Adjusted EBITDA also showed improvement, reaching $667,000 from a negative $95,000 in the first quarter of the previous year. Nephros Inc. continues to benefit from its proprietary technology and the growing demand driven by regulatory tailwinds. The company remains GAAP profitable and cash flow positive, supported by its strong balance sheet with no debt. The new executive team is focused on rationalizing and re-energizing the company as a leading provider in the water filtration industry.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nephros Inc. published the original content used to generate this news brief on May 22, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2537242059"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537242059\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2537242059?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-23 04:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537242059","market":"nz","top_or_hot":-1,"title":"Nephros Inc. Reports Significant Turnaround with $558K Net Income and $0.05 EPS, Rebounding from Previous Losses","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Nephros Inc. Reports Significant Turnaround with $558K Net Income and $0.05 EPS, Rebounding from Previous Losses\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Nephros Inc. has released its financial results for the first quarter of 2025, showing a net income of $558,000, a significant improvement compared to the net loss of $169,000 reported in the same quarter of the previous year. The company's earnings per share <a href=\"https://laohu8.com/S/EPS\">$(EPS)$</a>, both basic and diluted, stood at $0.05, compared to a loss of $0.02 per share in the first quarter of 2024. The company's EBITDA for the quarter was $585,000, marking a substantial turnaround from the negative EBITDA of $159,000 in the previous year's first quarter. Adjusted EBITDA also showed improvement, reaching $667,000 from a negative $95,000 in the first quarter of the previous year. Nephros Inc. continues to benefit from its proprietary technology and the growing demand driven by regulatory tailwinds. The company remains GAAP profitable and cash flow positive, supported by its strong balance sheet with no debt. The new executive team is focused on rationalizing and re-energizing the company as a leading provider in the water filtration industry.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nephros Inc. published the original content used to generate this news brief on May 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nephros Inc. Reports Significant Turnaround with $558K Net Income and $0.05 EPS, Rebounding from Previous Losses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNephros Inc. Reports Significant Turnaround with $558K Net Income and $0.05 EPS, Rebounding from Previous Losses\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-23 04:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Nephros Inc. Reports Significant Turnaround with $558K Net Income and $0.05 EPS, Rebounding from Previous Losses\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Nephros Inc. has released its financial results for the first quarter of 2025, showing a net income of $558,000, a significant improvement compared to the net loss of $169,000 reported in the same quarter of the previous year. The company's earnings per share <a href=\"https://laohu8.com/S/EPS\">$(EPS)$</a>, both basic and diluted, stood at $0.05, compared to a loss of $0.02 per share in the first quarter of 2024. The company's EBITDA for the quarter was $585,000, marking a substantial turnaround from the negative EBITDA of $159,000 in the previous year's first quarter. Adjusted EBITDA also showed improvement, reaching $667,000 from a negative $95,000 in the first quarter of the previous year. Nephros Inc. continues to benefit from its proprietary technology and the growing demand driven by regulatory tailwinds. The company remains GAAP profitable and cash flow positive, supported by its strong balance sheet with no debt. The new executive team is focused on rationalizing and re-energizing the company as a leading provider in the water filtration industry.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nephros Inc. published the original content used to generate this news brief on May 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NEPH","symbol_name":"Nephros, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL1gch8x:1","article_id":"2537242059","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537242059","pubTimestamp":1747944277,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Nephros Inc. has released its financial results for the first quarter of 2025, showing a net income of $558,000, a significant improvement compared to the net loss of $169,000 reported in the same quarter of the previous year. The company's earnings per share , both basic and diluted, stood at $0.05, compared to a loss of $0.02 per share in the first quarter of 2024. The company's EBITDA for the quarter was $585,000, marking a substantial turnaround from the negative EBITDA of $159,000 in the previous year's first quarter. Adjusted EBITDA also showed improvement, reaching $667,000 from a negative $95,000 in the first quarter of the previous year. Nephros Inc. continues to benefit from its proprietary technology and the growing demand driven by regulatory tailwinds. The company remains GAAP profitable and cash flow positive, supported by its strong balance sheet with no debt. The new executive team is focused on rationalizing and re-energizing the company as a leading provider in the wa","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"NEPH":"Nephros, Inc."},"translate_title":"Nephros Inc.报告实现显着扭亏为盈，净利润为55.8万美元，每股收益为0.05美元，从之前的亏损中反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NEPH":0.9},"content_text":"Nephros Inc. Reports Significant Turnaround with $558K Net Income and $0.05 EPS, Rebounding from Previous Losses\n    \n\n        Nephros Inc. has released its financial results for the first quarter of 2025, showing a net income of $558,000, a significant improvement compared to the net loss of $169,000 reported in the same quarter of the previous year. The company's earnings per share $(EPS)$, both basic and diluted, stood at $0.05, compared to a loss of $0.02 per share in the first quarter of 2024. The company's EBITDA for the quarter was $585,000, marking a substantial turnaround from the negative EBITDA of $159,000 in the previous year's first quarter. Adjusted EBITDA also showed improvement, reaching $667,000 from a negative $95,000 in the first quarter of the previous year. Nephros Inc. continues to benefit from its proprietary technology and the growing demand driven by regulatory tailwinds. The company remains GAAP profitable and cash flow positive, supported by its strong balance sheet with no debt. The new executive team is focused on rationalizing and re-energizing the company as a leading provider in the water filtration industry.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nephros Inc. published the original content used to generate this news brief on May 22, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}